ORDER THE SYNTap™ BIOMARKER TEST
Currently, Amprion offers the SYNTap Test on a self-pay basis. We are also working diligently to establish reimbursement from private insurance providers, Medicare, and Medicaid. Using CSF, this diagnostic test is commercially available in the US, except Maryland, New York, Pennsylvania, and Rhode Island. We anticipate rollout in these states within the next few months.